Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Parkinson’s Disease Drug Permax Ordered Off The Market By Health Canada
Permax Was Voluntarily Withdrawn From the U.S. Market Earlier This Year At The Insistence of FDA (Posted by Tom Lamb at DrugInjuryWatch.com) As you may recall, the Parkinson disease drug Permax was voluntarily withdrawn…
-
Women Using Cordarone Five Times More Likely To Need Pacemaker Than Women Who Did Not
Researchers Find There Is No Such Risk, However, For Men Using This Atrial Fibrillation Heart Drug (Posted by Tom Lamb at DrugInjuryWatch.com) An August 14, 2007 article published by Reuters, "Heart drug may lead…
-
FDA / Health Canada: Long Term Use Of Nexium And Prilosec May Cause Heart Attacks Or Cardiac Death
AstraZeneca Study Information Provided To Regulatory Agencies In May 2007 Currently The Subject of Their Ongoing Safety Reviews (Posted by Tom Lamb at DrugInjuryWatch.com) On August 9, 2007 the FDA and Health Canada issued…
-
Avandia Meta-Analysis By Nissen And Wolski Is Analyzed Further, And A Different Result Is Found
Risk For Heart Attack And Death From Cardiovascular Disease For Diabetic Patients Using Avandia: "Uncertain" (Posted by Tom Lamb at DrugInjuryWatch.com) On August 6, 2007 the medical journal Annals of Internal Medicine published online…
-
Drug Safety Update: A Promising New Monthly Electronic Bulletin From The UK’s Drug Agency
First Issue Includes Updated Advice Regarding Dostinex; Now A Second-Line Treatment Due To Increased Risk Of Serious Heart Valve Damage (Posted by Tom Lamb at DrugInjuryWatch.com) In the United Kingdom (UK) the Medicines and…
-
FDA Advisory Committees To Consider Risks And Benefits, If Any, Of Avandia At July 30 Meeting
July 2007 Cochrane Review Of Trials Contends That Avandia Is No Better Than Other Diabetes Drugs While Being Associated With Serious Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) On July 30, 2007 the…
-
Latest Avandia Heart Risk Findings Reported In July 5, 2007 NEJM Edition
Avandia Seems Associated With Increased Rate Of Heart Failure; Less Clear Whether Glaxo’s Diabetes Drug Causes Heart Attacks, Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In the July 5, 2007 edition of…
-
Safety Of Avandia Discussed At Diabetes Meeting By Doctors Nissen, Buse, And Home
Issues Include Publishing Of May 2007 NEJM Article And Whether To Keep Diabetic Patients On Avandia (Posted by Tom Lamb at DrugInjuryWatch.com) A lively discussion during a session about Avandia was the highlight of…
-
Following FDA’s Action, Novartis’ Zelnorm Gets Recall Order From Chinese Drug Regulator
China’s State Food & Drug Administration Says Zelnorm Side Effect Risks Outweigh This Drug’s Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) A June 8, 2007 Associated Press (AP) article published in The Washington Post…
-
Novartis Ordered To Recall Zelnorm From Market In Switzerland
Swiss Pharmaceutical Regulator States That Side Effect Risks Outweigh Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) In a brief June 1, 2007 Wall Street Journal (WSJ) article it was reported that Switzerland’s pharmaceuticals regulator…